Drugs · acquisition-cost intelligence
Dulera
mometasone furoate and formoterol fumarate dihydrate· ingredient mometasoneAdrenergics in combination with corticosteroids or other drugs, excl. anticholinergics· FORMOTEROL FUMARATE 5 ug/1; MOMETASONE FUROATE 100 ug/1; FORMOTEROL FUMARATE 5 ug/1; MOMETASONE FUROATE 200 ug/1; FORMOTEROL FUMARATE 5 ug/1; MOMETASONE FUROATE 50 ug/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$25.23
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other mometasone products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| Mometasone furoate | $0.26779 | −$24.97 |
| Mometasone Furoate | $0.34950 | −$24.88 |
| Mometasone Furoate | $0.48662 | −$24.75 |
| allergy | $1.43 | −$23.80 |
| ASMANEX HFA | $7.38 | −$17.86 |
| Ryaltris | $7.69 | −$17.55 |
| ASMANEX | $104.30 | +$79.06 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.